Table 4 (cont'd) Patient No. & sex Age at surgery Years post exposure Pathologic diagnosis Remarks Utirik exposed 2229 F 32 15 1/2 Follicular carcinoma 2208 F 2212 F 53 53 19 19 Adenomatous nodules Adenomatous nodules with Hurthle cell 2221 F 73 19 Adenomatous nodules with follicular Hyperplasia, focal atypia 2160 F 2150 M 2194 F 2261x M 2236 M 2193 F 2195 F 25 34 59 50 35 56 49 21 22 22 23 24 25 25 Papillary carcinoma Follicular adenoma Papillary carcinoma No diagnostic lesion Follicular adenoma Adenomatous nodules Adenomatous nodule Hyperplasia 2215 F 2147 2196 2239 2132 F F F F adenoma 1/2 1/2 1/2 1/2 58 ° 25 1/2 30 63 29 28 -25 1/2 26 1/2 27 27 adenoma Divided opinion: atypical adenoma Hyperplasia Lymph node metastases Focal hyperplasia Papillary hyperplasia Adenomatous nodules with occult papillary carcinoma Adenomatous nodules Diffuse Adenomatous nodules Adenomatous nodules Adenomatous nodule Fibrosis Rongelap unexposed controls 938 F 829 F 841 F 1007 1573 867 4023 1556 M M F F F a Suc| 33 41 41 66 28 50 44 34 Adenomatous nodule Adenomatous nodule Papillary hyperplasia Adenomatous nodules with occult papillary carcinoma Papillary carcinoma Fibrosis, hyperplasia Papillary carcinoma Adenomatous nodule Fibrosis Adenomatous nodule Papillary hyperplasia No diagnostic lesion - 65 -